Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Garedew 2005 Eur Shock Soc

From Bioblast
Revision as of 19:18, 13 April 2017 by Gnaiger Erich (talk | contribs)
Publications in the MiPMap
Garedew A, Hütter E, Haffner B, Gradl P, Gradl L, Jansen-Dürr P, Gnaiger E (2005) High-resolution respirometry for the study of mitochondrial function in health and disease. The OROBOROS O2k. Proc 11th Congress Eur Shock Soc, Vienna, Austria (Redl H, ed) Medimond, Bologna:107-11.

» Bioblast Access

Garedew A, Huetter E, Haffner B, Gradl P, Gradl L, Jansen-Duerr P, Gnaiger E (2005) Medimond

Abstract: High-resolution respirometry with mitochondria, cells or biopsies is based on the unique features of the OROBOROS O2k, combining instrumental design, electronics and task-specific DatLab software. Various respiratory states are analyzed with <0.4 million cells or <4 mg biopsy (muscle, liver) per assay. Complex substrate/inhibitor titration protocols are used to quantify functional properties of selected components of the respiratory chain. The electronic titration-injection micropump TIP2k is applied for kinetics as a modular component of the O2k. DatLab provides on-line instrumental background corrections of oxygen flux and on-line data analysis, and tabulated results are available at the end of an experiment. This sets a new standard for biomedical and clinical studies, combining high-resolution with instant diagnostic information.


O2k-Network Lab: AT Innsbruck Gnaiger E, AT Innsbruck Jansen-Duerr P, AT Innsbruck OROBOROS


Labels: MiParea: Respiration, Instruments;methods 


Organism: Human  Tissue;cell: Fibroblast  Preparation: Intact cells 

Regulation: Uncoupler  Coupling state: OXPHOS 

HRR: Oxygraph-2k, TIP2k 



The present paper is fully quality controlled, but concerns emerged about the integrity of the first author


LinkedIn

From https://www.linkedin.com/in/assegid/ 2017-04-10
Assa Oumie - Currently Senior Analytical Development Scientist at Cell Therapy Catapult, growing the UK cell and gene therapy industry, delivering health and wealth. Previous to this I worked as a Lead Staff Scientist at Affymetrix UK for an NHS Diagnostic Lab-Academic Research Lab-CRO- Biotech collaborative R&D project, co-funded by the Innovate UK-Stratified Medicine Programme, to develop the OncoScan Assay for tumour genomic profiling.
As a Post Doctoral Researcher of Cell and Molecular Biology at University College London (UCL) I studied cell metabolism and identified therapeutic targets against inflammation and statin-induced myopathy, in collaboration with academic and industrial partners. During my career at UCL I secured funding from research council, charity and pharmaceutical industry for three major research projects, supervised the research projects of students and junior staff and delivered module courses to graduate students.
As a Business Development Associate and Post-Doctoral Researcher at Innsbruck Medical University (Austria) in partnership with a spin-out company, I played key roles in cell biology research, oxygen sensor and software development and validation, and customer technical support. Before moving to Innsbruck, I worked at the Medical Faculty of the University of Würzburg (Germany) where I conducted comparative metabolic investigation, on cancer and foetal cells, to better understand the mechanism of adaptation to hypoxia.
Declaration
Assegid Garedew but not Assa Oumie (no person of that name is known to us) was a Postdoc employed by our 'spin-out company' working at the Medical University of Innsbruck (DSL Research Laboratory) after moving to Innsbruck from the University of Würzburg. ~ Gnaiger Erich (talk) 14:01, 10 April 2017 (CEST)